Reid M. Huber

Leeftijd : 49

Vermogen : 27 487 USD

Belangrijkste bedrijven :

Tango Therapeutics, Inc. -

Bellicum Pharmaceuticals, Inc.

Overzicht

Presently, Reid M. Huber is Partner at Third Rock Ventures LLC.

He is also on the board of 5 other companies.

In the past he was Chief Scientific Officer & Executive VP at Incyte Corp. and Principal Research Scientist at DuPont Pharmaceuticals Co.

Dr. Huber received an undergraduate degree from Murray State University (Kentucky) and a doctorate from Washington University School of Medicine.

Posities en verantwoordelijkheden van Reid M. Huber

Naam	Titel	Van
Tango Therapeutics, Inc. (Biotechnologie & Medisch Onderzoek)	Independent Director	2019
Bellicum Pharmaceuticals, Inc. (Biotechnologie & Medisch Onderzoek)	Independent Director	2014
Tango Therapeutics Sub, Inc.	Director	2019
Asher Biotherapeutics, Inc.	Director	2021
MOMA Therapeutics, Inc.	Director	2021
Third Rock Ventures LLC	Partner	2018

Belangnemingen van Reid M. Huber

Naam	Aandelen	%	Totale waarde
Bellicum Pharmaceuticals, Inc. (BLCM) (Biotechnologie & Medisch Onderzoek)	19 494	0,23%	27 487 USD

Reid M. HuberPersoonlijk netwerk

Naam	Verwante bedrijven
Barbara L. Weber	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc. Third Rock Ventures LLC
Alexis Borisy	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc. Third Rock Ventures LLC
Malte Peters	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc.
Christoph S. Lengauer	MOMA Therapeutics, Inc. Third Rock Ventures LLC
Lesley Ann Calhoun	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc.
Daniella Beckman	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc.
Aaron I. Davis	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc.
Mace L. Rothenberg	Tango Therapeutics, Inc. Tango Therapeutics Sub, Inc.
Cary G. Pfeffer	Tango Therapeutics Sub, Inc. Third Rock Ventures LLC
James M. Daly	Bellicum Pharmaceuticals, Inc.